Merck & Co Inc
featured
The ASCO meeting scheduled to begin on May 31st could generate a cornucopia of health care catalysts, said Jim Cramer.
» Read More
More
-
The ASCO meeting scheduled to begin on May 31st could generate a cornucopia of health care catalysts, said Jim Cramer.
-
May 20- Merck& Co's experimental insomnia drug suvorexant appears generally effective, according to reviewers at the U.S. Food and Drug Administration, but they questioned the company's proposed dosing levels.
-
After trying its products this Hollywood star bought an equity stake in the company. Could her endorsement lead to an IPO?
-
Baxter International Inc. rose$. 68 or. 9 percent, to $72.53. Bristol-Myers Squibb Co. rose$. 19 or. 4 percent, to $42.96. Hospira rose$. 06 or. 2 percent, to $35.78.
-
NEW YORK-- A look at New York Stock Exchange 10 most-active stocks at 1 p.m.:. Advanced Micro Devices Inc. rose 6.0 percent to $4.06 with 21,590,400 shares traded. Bank of America Corp. rose. 4 percent to $13.42 with 53,087,000 shares traded.
-
Baxter International Inc. rose$. 99 or 1.4 percent, to $72.84. Bristol-Myers Squibb Co. rose$. 28 or. 7 percent, to $43.05. Hospira rose$. 28 or. 8 percent, to $36.00.
-
Baxter International Inc. rose$. 82 or 1.2 percent, to $71.37. Bristol-Myers Squibb Co. fell $1.64 or 3.7 percent, to $42.70. Hospira rose $1.33 or 3.8 percent, to $35.76.
-
Baxter International Inc. fell$. 05 or. 1 percent, to $70.50. Bristol-Myers Squibb Co. fell$. 53 or 1.2 percent, to $43.81. Hospira rose$. 27 or. 8 percent, to $34.70.
-
Baxter International Inc. rose$. 02 or percent, to $70.51. Bristol-Myers Squibb Co. rose $2.90 or 6.9 percent, to $45.11. Hospira rose$. 02 or. 1 percent, to $34.27.
-
Baxter International Inc. fell$. 03 or percent, to $70.46. Bristol-Myers Squibb Co. rose$. 42 or 1.0 percent, to $42.63. Hospira fell$. 04 or. 1 percent, to $34.21.
-
NEW YORK-- Moody's Investors Service on Tuesday lowered the long-term debt ratings of drug maker Merck& Co.. Moody's Senior Vice President Michael Levesque said Tuesday that the company's credit ratios will steadily weaken but remain solid as it completes the buyback program.
-
Baxter International Inc. rose$. 39 or. 6 percent, to $70.85. Bristol-Myers Squibb Co. rose $1.03 or 2.5 percent, to $41.97. Hospira fell$. 06 or. 2 percent, to $34.17.
-
Baxter International Inc. rose$. 33 or. 5 percent, to $70.79. Bristol-Myers Squibb Co. rose$. 63 or 1.5 percent, to $41.57. Hospira rose$. 05 or. 1 percent, to $34.28.
-
Baxter International Inc. fell$. 03 or percent, to $70.74. Bristol-Myers Squibb Co. rose$. 24 or. 6 percent, to $40.73. Hospira fell$. 19 or. 5 percent, to $34.43.
-
Baxter International Inc. fell$. 34 or. 5 percent, to $70.42. Bristol-Myers Squibb Co. rose$. 11 or. 3 percent, to $40.60. Hospira fell$. 19 or. 6 percent, to $34.43.
-
Companies like Pfizer Inc and AstraZeneca have grown dependent on higher U.S. prices to generate profits as generic rivals to their best-selling medicines enter the world market, Europe's government-run health plans clamp down on spending and sales growth in emerging markets stutters.
-
Baxter International Inc. fell$. 30 or. 4 percent, to $70.69. Bristol-Myers Squibb Co. rose$. 22 or. 6 percent, to $40.15. Hospira rose$. 04 or. 1 percent, to $34.59.
-
Baxter International Inc. rose$. 03 or percent, to $71.02. Bristol-Myers Squibb Co. rose$. 25 or. 6 percent, to $40.18. Hospira fell$. 02 or. 1 percent, to $34.53.
-
Baxter International Inc. rose$. 02 or percent, to $71.29. Bristol-Myers Squibb Co. rose$. 13 or. 3 percent, to $39.81. Hospira rose$. 75 or 2.2 percent, to $34.35.
-
May 9- A senior sales representative for Merck& Co has sued the drugmaker for more than $100 million, alleging it discriminates against female employees in terms of pay and advancement, particularly pregnant employees and women with children.